Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
3(60.0%)
N/A
2(40.0%)
5Total
Phase 4(3)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07566455Phase 4Completed

Comparing Intra-Umbilical Versus Intravenous Oxytocin in Women During the Third Stage of Labor for Reducing Blood Loss

Role: lead

NCT07486245Not ApplicableCompleted

Comparison of Post-Operative Endodontic Pain Using Sodium Hypochlorite, Hydrogen Peroxide, and Normal Saline as Root Canal Irrigants

Role: lead

NCT07379762Phase 4Completed

Intramuscular Versus Rectal Diclofenac for Pain Relief After Cesarean Section in Women

Role: lead

NCT07338097Not ApplicableEnrolling By Invitation

Comparison of Bevacizumab and Aflibercept in Treatment of Diabetic Macular Edema

Role: lead

NCT06911034Phase 4Completed

Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women

Role: lead

All 5 trials loaded